TrialClinical pharmacokinetics2022

Population Pharmacokinetics of Asciminib in Tyrosine Kinase Inhibitor-Treated Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic and Acute Phases.

Ying Fei Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.